Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

MICHAEL R MACADAMS

Allopathic & Osteopathic Physicians Internal Medicine Endocrinology, Diabetes & Metabolism

NPI
1477611044
CMS profile
21291
Location
LUBBOCK, TX

General Payments · PY2018–2024

$10,802.43

  • Reported across 694 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$529.50

37 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $529.50 37

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Lilly USA, LLC $139.29 9
Abbott Laboratories $134.20 16
Amgen Inc. $80.42 3
Radius Health, Inc. $34.56 2
Novo Nordisk AS $33.68 2
Bayer HealthCare Pharmaceuticals Inc. $28.41 1
DEXCOM, INC. $22.09 1
SANOFI-AVENTIS U.S. LLC $21.92 1
ABBVIE INC. $19.84 1
Esperion Therapeutics, Inc. $15.09 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $2,180.29 126
PY2019 $2,082.71 130
PY2020 $1,703.04 113
PY2021 $1,690.59 105
PY2022 $1,710.32 117
PY2023 $905.98 66
PY2024 $529.50 37

Payment records · PY2024 (37)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Abbott Laboratories $3.89 01/29/2024 Food and Beverage Undisputed 01/23/2026 1125084579 CMS
Abbott Laboratories $17.16 04/02/2024 Food and Beverage Undisputed 01/23/2026 1125084581 CMS
Abbott Laboratories $2.47 04/10/2024 Food and Beverage Undisputed 01/23/2026 1125084583 CMS
Abbott Laboratories $10.20 04/26/2024 Food and Beverage Undisputed 01/23/2026 1125084585 CMS
Abbott Laboratories $7.32 04/26/2024 Food and Beverage Undisputed 01/23/2026 1125084587 CMS
Abbott Laboratories $12.37 07/02/2024 Food and Beverage Undisputed 01/23/2026 1125084589 CMS
Abbott Laboratories $4.47 07/03/2024 Food and Beverage Undisputed 01/23/2026 1125084591 CMS
Abbott Laboratories $10.20 07/03/2024 Food and Beverage Undisputed 01/23/2026 1125084609 CMS
Abbott Laboratories $6.69 09/13/2024 Food and Beverage Undisputed 01/23/2026 1125084603 CMS
Abbott Laboratories $9.80 09/13/2024 Food and Beverage Undisputed 01/23/2026 1125084605 CMS
Abbott Laboratories $19.18 09/13/2024 Food and Beverage Undisputed 01/23/2026 1125084607 CMS
Abbott Laboratories $4.32 10/07/2024 Food and Beverage Undisputed 01/23/2026 1125084593 CMS
Abbott Laboratories $6.66 10/09/2024 Food and Beverage Undisputed 01/23/2026 1125084595 CMS
Abbott Laboratories $5.87 12/10/2024 Food and Beverage Undisputed 01/23/2026 1125084597 CMS
Abbott Laboratories $4.88 12/16/2024 Food and Beverage Undisputed 01/23/2026 1125084599 CMS
Abbott Laboratories $8.72 12/26/2024 Food and Beverage Undisputed 01/23/2026 1125084601 CMS
ABBVIE INC. $19.84 02/01/2024 Food and Beverage Undisputed 01/23/2026 1104918098 CMS
Amgen Inc. $21.75 02/09/2024 Food and Beverage Undisputed 01/23/2026 1115889036 CMS
Amgen Inc. $31.79 02/28/2024 Food and Beverage Undisputed 01/23/2026 1115889043 CMS
Amgen Inc. $26.88 10/29/2024 Food and Beverage Undisputed 01/23/2026 1115889049 CMS
Bayer Healthcare Pharmaceuticals Inc. $28.41 09/05/2024 Food and Beverage Undisputed 01/23/2026 1086186718 CMS
Dexcom, Inc. $22.09 03/27/2024 Food and Beverage Undisputed 01/23/2026 1153322330 CMS
Esperion Therapeutics, Inc. $15.09 12/05/2024 Food and Beverage Undisputed 01/23/2026 1129444994 CMS
Lilly USA, LLC $12.79 01/08/2024 Food and Beverage Undisputed 01/23/2026 1135172812 CMS
Lilly USA, LLC $22.53 02/16/2024 Food and Beverage Undisputed 01/23/2026 1135172814 CMS
Lilly USA, LLC $10.77 04/05/2024 Food and Beverage Undisputed 01/23/2026 1135222561 CMS
Lilly USA, LLC $10.07 05/03/2024 Food and Beverage Undisputed 01/23/2026 1135231632 CMS
Lilly USA, LLC $24.52 05/10/2024 Food and Beverage Undisputed 01/23/2026 1135242459 CMS
Lilly USA, LLC $10.65 05/31/2024 Food and Beverage Undisputed 01/23/2026 1135172816 CMS
Lilly USA, LLC $12.62 07/19/2024 Food and Beverage Undisputed 01/23/2026 1135231628 CMS
Lilly USA, LLC $16.18 08/23/2024 Food and Beverage Undisputed 01/23/2026 1135197276 CMS
Lilly USA, LLC $19.16 10/31/2024 Food and Beverage Undisputed 01/23/2026 1135172818 CMS
Novo Nordisk Inc $15.76 04/30/2024 Food and Beverage Undisputed 01/23/2026 1096899780 CMS
Novo Nordisk Inc $17.92 09/24/2024 Food and Beverage Undisputed 01/23/2026 1096684557 CMS
Radius Health, Inc. $20.77 04/03/2024 Food and Beverage Undisputed 01/23/2026 1089976247 CMS
Radius Health, Inc. $13.79 10/02/2024 Food and Beverage Undisputed 01/23/2026 1089976251 CMS
SANOFI-AVENTIS U.S. LLC $21.92 06/04/2024 Food and Beverage Undisputed 01/23/2026 1139587381 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.